Ensign Peak Advisors
FMTX

Ensign Peak Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Ensign Peak Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,580
Closed -$32K – 2385
2022
Q2 		$32K Hold
4,580
– – ﹤0.01% 2104
2022
Q1 		$43K Hold
4,580
– – ﹤0.01% 2141
2021
Q4 		$65K Buy
+4,580
New +$79.2K ﹤0.01% 2119

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Ensign Peak Advisors's FMTX Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 4,580 shares — an estimated $32K sold.

Ensign Peak Advisors first reported a position in FMTX in Q4 2021 and held it in 3 quarters. The position peaked at $65K in Q4 2021. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

  • Ensign Peak Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 4,580 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $32K.
  • Ensign Peak Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Ensign Peak Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $65K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.